• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢化可的松持续速率输注与地塞米松推注治疗犬肾上腺危象的回顾性研究。

A retrospective study of hydrocortisone continuous rate infusion compared with administration of dexamethasone boluses in dogs with adrenal crisis.

机构信息

Emergency & Critical Care Specialist Service, VetsNow 24/7 Pet Emergency & Specialty Hospital, Glasgow, UK.

The Royal (Dick) School of Veterinary Studies and the Roslin Institute, Easter Bush Campus, The University of Edinburgh, Midlothian, UK.

出版信息

J Vet Intern Med. 2024 Mar-Apr;38(2):951-959. doi: 10.1111/jvim.17017. Epub 2024 Feb 14.

DOI:10.1111/jvim.17017
PMID:38353573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10937513/
Abstract

BACKGROUND

Evidence indicating the optimal treatment protocol for dogs in adrenal crisis is lacking.

OBJECTIVES

Compare outcomes of dogs presented in adrenal crisis treated with either hydrocortisone (HC) continuous rate infusion (CRI) or intermittent dexamethasone (DEX) administration.

ANIMALS

Thirty-nine client-owned dogs.

METHODS

Multi-institutional retrospective observational study (July 2016-May 2022) including dogs diagnosed with adrenal crisis and with available sequential blood work during hospitalization. Dogs were excluded if already on treatment with exogenous corticosteroids. Outcomes assessed included duration of hospitalization, survival, number of repeat measurements of electrolyte concentrations, and time to normalization of electrolyte and acid-base status.

RESULTS

No significant difference was found between the groups for hospitalization time (P = .41; HC median [range] 48 h [19-105 h]; DEX 57 h [17-167 h]) nor case fatality rate 2/28 in the DEX group and 0/11 in the HC group (P = 1), nor in number of measurements of electrolyte concentrations (P = .90; HC 4 [2-10]; DEX 4.5 [2-15]). No significant differences were found between the 2 treatment groups in time to normalization of serum Na (P = .30; HC 33 h [7-66 h]; DEX 16 h [1.5-48 h]), K (P = .92; HC 17 h [4-48 h]; DEX 16 h [1.25-60 h]) or Na/K ratio (P = .08; HC 17 h [8-48 h]; DEX 26 h [1.5-60 h]).

CONCLUSIONS

This study detected no difference in outcomes for dogs in adrenal crisis treated with either DEX boluses or HC CRIs.

摘要

背景

缺乏关于犬肾上腺危象最佳治疗方案的证据。

目的

比较使用氢化可的松(HC)持续速率输注(CRI)或间断地塞米松(DEX)治疗的肾上腺危象犬的治疗结果。

动物

39 只患犬。

方法

多机构回顾性观察研究(2016 年 7 月至 2022 年 5 月),纳入诊断为肾上腺危象且住院期间有连续血液检查结果的犬。已接受外源性皮质类固醇治疗的犬被排除在外。评估的结果包括住院时间、存活率、电解质浓度重复测量次数以及电解质和酸碱状态正常化的时间。

结果

两组在住院时间(P = .41;HC 中位数[范围]48 h[19-105 h];DEX 57 h[17-167 h])、病死率(DEX 组 2/28,HC 组 0/11,P = 1)或电解质浓度测量次数(P = .90;HC 4[2-10];DEX 4.5[2-15])方面均无显著差异。两组在血清钠正常化时间(P = .30;HC 33 h[7-66 h];DEX 16 h[1.5-48 h])、钾(P = .92;HC 17 h[4-48 h];DEX 16 h[1.25-60 h])或钠/钾比值(P = .08;HC 17 h[8-48 h];DEX 26 h[1.5-60 h])方面也无显著差异。

结论

本研究未发现用 DEX 推注或 HC CRI 治疗的肾上腺危象犬的治疗结果有差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/bf206f241b88/JVIM-38-951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/f8d8967fac20/JVIM-38-951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/0a684e06abb0/JVIM-38-951-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/a8e88b52aa4a/JVIM-38-951-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/e13140075f77/JVIM-38-951-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/c307a0a1449f/JVIM-38-951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/d55be4b61c90/JVIM-38-951-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/bf206f241b88/JVIM-38-951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/f8d8967fac20/JVIM-38-951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/0a684e06abb0/JVIM-38-951-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/a8e88b52aa4a/JVIM-38-951-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/e13140075f77/JVIM-38-951-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/c307a0a1449f/JVIM-38-951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/d55be4b61c90/JVIM-38-951-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10937513/bf206f241b88/JVIM-38-951-g001.jpg

相似文献

1
A retrospective study of hydrocortisone continuous rate infusion compared with administration of dexamethasone boluses in dogs with adrenal crisis.氢化可的松持续速率输注与地塞米松推注治疗犬肾上腺危象的回顾性研究。
J Vet Intern Med. 2024 Mar-Apr;38(2):951-959. doi: 10.1111/jvim.17017. Epub 2024 Feb 14.
2
Comparison of Hydrocortisone Continuous Rate Infusion and Prednisolone or Dexamethasone Administration for Treatment of Acute Hypoadrenocortical (Addisonian) Crisis in Dogs.氢化可的松持续速率输注与泼尼松龙或地塞米松给药治疗犬急性肾上腺皮质功能减退(艾迪生病)危象的比较。
Front Vet Sci. 2022 Jan 25;8:818515. doi: 10.3389/fvets.2021.818515. eCollection 2021.
3
Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.新生儿期使用地塞米松与氢化可的松治疗慢性肺病后学龄期行为结果和运动发育的差异。
Pediatr Res. 2006 Dec;60(6):745-50. doi: 10.1203/01.pdr.0000246200.76860.de. Epub 2006 Oct 25.
4
Retrospective evaluation of the use of hydrocortisone for treatment of suspected critical illness-related corticosteroid insufficiency (CIRCI) in dogs with septic shock (2010-2017): 47 cases.回顾性评估氢化可的松治疗疑似脓毒性休克犬危重病相关皮质激素不足(CIRCI)的效果(2010-2017 年):47 例。
J Vet Emerg Crit Care (San Antonio). 2021 May;31(3):371-379. doi: 10.1111/vec.13037. Epub 2021 Feb 17.
5
Neonatal glucocorticoid treatment: long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents.新生儿糖皮质激素治疗:对 14-17 岁青少年下丘脑-垂体-肾上腺轴、免疫系统和问题行为的长期影响。
Brain Behav Immun. 2015 Mar;45:128-38. doi: 10.1016/j.bbi.2014.10.017. Epub 2014 Nov 8.
6
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.用于治疗先天性肾上腺皮质增生症的糖皮质激素替代方案。
Cochrane Database Syst Rev. 2020 Mar 19;3(3):CD012517. doi: 10.1002/14651858.CD012517.pub2.
7
Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?新生儿糖皮质激素治疗的短期和长期影响:氢化可的松能否替代地塞米松?
Acta Paediatr. 2003 Jul;92(7):827-35. doi: 10.1080/08035250310002425.
8
Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model.用地药代动力学模型评估地塞米松给药对血浆氢化可的松抑制的时间依赖性效应。
J Pharmacol Exp Ther. 1992 Aug;262(2):503-8.
9
Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone.曲安奈德对培养的人视网膜色素上皮细胞的细胞毒性:与地塞米松和氢化可的松的比较
Jpn J Ophthalmol. 2004 May-Jun;48(3):236-42. doi: 10.1007/s10384-003-0053-8.
10
Kinetic-dynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone.吸入和静脉注射地塞米松后,地塞米松与氢化可的松联合作用诱导人体淋巴细胞减少的动力学-动态建模。
J Pharmacol Exp Ther. 1992 Aug;262(2):509-15.

引用本文的文献

1
Comparison of prednisolone and alternative glucocorticoid dosing protocols for canine hypoadrenocorticism: insights from a survey-based study.泼尼松龙与替代糖皮质激素给药方案治疗犬肾上腺皮质功能减退症的比较:一项基于调查研究的见解
Front Vet Sci. 2025 Apr 14;12:1544750. doi: 10.3389/fvets.2025.1544750. eCollection 2025.
2
Clinical findings, treatment, and outcomes in cats with naturally occurring hypoadrenocorticism: 41 cases.患有自然发生的肾上腺皮质功能减退症的猫的临床发现、治疗及结果:41例病例
J Vet Intern Med. 2025 Jan-Feb;39(1):e17243. doi: 10.1111/jvim.17243.

本文引用的文献

1
Comparison of Hydrocortisone Continuous Rate Infusion and Prednisolone or Dexamethasone Administration for Treatment of Acute Hypoadrenocortical (Addisonian) Crisis in Dogs.氢化可的松持续速率输注与泼尼松龙或地塞米松给药治疗犬急性肾上腺皮质功能减退(艾迪生病)危象的比较。
Front Vet Sci. 2022 Jan 25;8:818515. doi: 10.3389/fvets.2021.818515. eCollection 2021.
2
Hypoadrenocorticism in dogs under UK primary veterinary care: frequency, clinical approaches and risk factors.英国初级兽医护理下犬类肾上腺皮质功能减退症:发病率、临床治疗方法及风险因素
J Small Anim Pract. 2021 May;62(5):343-350. doi: 10.1111/jsap.13285. Epub 2021 Feb 8.
3
Adrenal Crisis.
肾上腺危象
N Engl J Med. 2019 Aug 29;381(9):852-861. doi: 10.1056/NEJMra1807486.
4
Management of hypoadrenocorticism (Addison's disease) in dogs.犬肾上腺皮质功能减退症(艾迪生病)的管理
Vet Med (Auckl). 2018 Feb 9;9:1-10. doi: 10.2147/VMRR.S125617. eCollection 2018.
5
Hydrocortisone in the management of acute hypoadrenocorticism in dogs: a retrospective series of 30 cases.氢化可的松用于犬急性肾上腺皮质功能减退症的治疗:30例回顾性病例系列
J Small Anim Pract. 2016 May;57(5):227-33. doi: 10.1111/jsap.12473. Epub 2016 Apr 21.
6
A review of the genetics of hypoadrenocorticism.肾上腺皮质功能减退症的遗传学综述。
Top Companion Anim Med. 2014 Dec;29(4):96-101. doi: 10.1053/j.tcam.2015.01.001. Epub 2015 Jan 5.
7
Canine hypoadrenocorticism: pathogenesis, diagnosis, and treatment.犬肾上腺皮质功能减退症:发病机制、诊断与治疗
Top Companion Anim Med. 2014 Dec;29(4):88-95. doi: 10.1053/j.tcam.2014.10.001. Epub 2014 Oct 17.
8
Basal serum cortisol concentration as a screening test for hypoadrenocorticism in dogs.基础血清皮质醇浓度作为犬肾上腺皮质功能减退症的筛查试验。
J Vet Intern Med. 2014 Sep-Oct;28(5):1541-5. doi: 10.1111/jvim.12415. Epub 2014 Jul 28.
9
A candidate gene analysis of canine hypoadrenocorticism in 3 dog breeds.犬三种品种低肾上腺皮质功能减退候选基因分析。
J Hered. 2013 Nov-Dec;104(6):807-20. doi: 10.1093/jhered/est051. Epub 2013 Aug 31.
10
Canine hypoadrenocorticism: part II.犬肾上腺皮质功能减退症:第二部分。
Can Vet J. 2010 Feb;51(2):179-84.